Davinder Singh Brar

D.S. Brar has been associated with the pharmaceutical industry for over three decades. He spent major part of his career (1977 – 2004) with Ranbaxy Laboratories Limited at various positions and rose to the level of President in 1993. He became the CEO and Managing Director of Ranbaxy in 1999. Mr. Brar stepped down from this position in 2004 to start his entrepreneurial journey and ventured with GVK Biosciences – a leading contract research and development organization providing discovery and development services to global life sciences companies. He also promoted Inogent Labs – an early development/ scale up company (now a wholly owned subsidiary of GVK Biosciences) and Davix Management Services – a pharmaceuticals focused consulting/advisory services company. Mr. Brar is the Chairman of Mphasis Limited and holds board positions in various Indian and international companies like Maruti Suzuki India Limited, Wockhardt Limited, Gland Pharma Limited and Mountain Trail Foods (India) Pvt. Ltd. He is also a special advisor to the Board of Directors of Adamas Pharmaceuticals Inc. and a member of the Advisory Board of the USA-India Chamber of Commerce (USAIC). From 2000–2007, Mr. Brar served as a Director of the Reserve Bank of India (RBI) and was also a member of the Inspection and Audit Sub-Committee of the Central Board of Directors of the RBI. Mr. Brar also served as a Senior Advisor to Kohlberg Kravis Roberts (KKR) – a global investment firm from 2011–2015.

Mr. Brar has also been actively involved with some of the premier research institutions, educational institutions and industry associations in India.